CreditReports.dk
HomeScreen companies

MedTrace Pharma A/S Financials, key figures and credit report

CVR number: 36497661 Established 2015 Industry: 77 Rental and leasing activities
Company contact details
Agern Alle 5 A, 2970 Hørsholm connect@medtrace.dk tel: 31388581 www.medtrace.dk
Net sales 1 759.4 kDKK FY 2025 -24.6% vs 2024
EBIT margin -1 471.6 % FY 2025 -464.2 pp vs 2024
Net debt -22 966.7 kDKK FY 2025 +30.8% vs 2024
Quick ratio 2.0 FY 2025 -1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales1 529.102 192.842 645.342 334.361 759.37
Other operating income831.19173.86230.35107.40
Costs of manufacturing-1 155.57- 269.58- 606.28-2 098.28-2 061.54
Gross profit373.531 923.262 039.06236.08- 302.17
Costs of management-12 721.21-15 944.00-5 016.13-5 933.03-7 257.77
Costs of distribution-1 319.84-5 328.70-5 687.41
Other operating expenses-11 638.41-29 876.32-11 637.40-17 925.82-18 330.63
EBIT-24 474.74-49 051.90-20 071.53-23 515.37-25 890.57
Other financial income41.6370.683 505.464 004.40810.30
Other financial expenses- 445.15- 973.43-1 591.23-1 294.96- 851.99
Pre-tax profit-24 878.26-49 969.57-18 157.30-20 805.93-25 932.26
Income taxes7 026.5712 919.173 050.805 450.05-9 198.85
Net earnings-17 851.68-37 050.40-15 106.50-15 355.88-35 131.11

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights62 658.3279 400.13149 702.73222 612.52284 254.22
Intangible assets total62 658.3279 400.13149 702.73222 612.52284 254.22
Machinery and equipment6 512.567 888.847 342.0510 236.598 912.25
Other tangible assets2 002.2411 700.809 658.967 139.804 765.44
Tangible assets total8 514.8119 589.6417 001.0117 376.3913 677.69
Other non-current investments767.57-1 473.031 331.101 517.141 536.01
Investments total767.57-1 473.031 331.101 517.141 536.01
Deferred tax assets2 426.86
Long term receivables total2 426.86
Inventories total404.084 307.235 996.822 462.301 434.94
Current trade debtors13 771.32544.56
Current other receivables3 337.8911 487.635 746.17-7 962.306 583.21
Current deferred tax assets5 500.005 500.005 500.005 500.005 500.00
Short term receivables total8 837.8916 987.6311 246.1711 309.0212 627.77
Cash and bank deposits38 333.3469 446.26122 317.4134 317.3223 564.26
Cash and cash equivalents38 333.3469 446.26122 317.4134 317.3223 564.26
Balance sheet total (assets)119 516.00190 684.72307 595.24289 594.69337 094.89

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital2 010.492 716.084 996.835 000.6611 178.91
Other reserves-70.49-85.41-90.50-66.48- 203.70
Retained earnings109 618.22195 610.31295 437.49280 486.43326 769.54
Profit of the financial year-17 851.68-37 050.40-15 106.50-15 355.88-35 131.11
Shareholders equity total93 706.53161 190.57285 237.32270 064.73302 613.64
Non-current loans from credit institutions5 484.203 749.571 006.49525.65
Non-current leasing loans68.506 119.346 119.343 869.532 256.91
Non-current deferred tax liabilities5 069.3514 301.01
Non-current liabilities total10 622.059 868.917 125.834 395.1816 557.91
Current loans from credit institutions152.32609.28609.28597.59
Current leasing loans210.191 884.781 164.092 074.192 110.27
Current trade creditors9 141.603 267.136 278.844 795.446 035.36
Other non-interest bearing current liabilities546.4712 171.575 415.786 472.399 081.44
Accruals and deferred income5 289.152 149.441 764.111 183.4898.67
Current liabilities total15 187.4119 625.2415 232.0915 134.7817 923.33
Balance sheet total (liabilities)119 516.00190 684.72307 595.24289 594.69337 094.89
Page generated